ILC2s: Unraveling the innate immune orchestrators in allergic inflammation
Article in International Immunopharmacology (March 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Article in Journal of Asthma and Allergy (March 2024)
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics
Article in The Journal of Allergy and Clinical Immunology In Practice (January 2024)